Ramit Ravona-Springer

Prof. Ramit Ravona-Springer


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 May 2012 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
PDF file
RRRamit Ravona-Springer
Ramit Ravona-Springer
EMErin Moshier
Erin Moshier
JSJames Schmeidler
James Schmeidler
JGJames Godbold
James Godbold
JAJimmy Akrivos
Jimmy Akrivos
MBMichal Schnaider Beeri
Michal Schnaider Beeri
The aim of the present study was to examine the relationship of changes in long term glucose levels as measured by Hemoglobin A1c (HbA1c) with simultaneous changes in cognition. The sample included in the present analysis consisted of 101 community d

30 April 2013 in Neurology
Verified
Journal Article
Closed access
PDF file
RRRamit Ravona-Springer
Ramit Ravona-Springer
MSMichal Schnaider-Beeri
Michal Schnaider-Beeri
UGUri Goldbourt
Uri Goldbourt
Objective: To analyze the relationship between body weight variability and dementia more than 3 decades later. Methods: The measurement of body weight variability was based on 3 successive weight recordings taken from over 10,000 apparently healthy tenured working men participating in the Israel Ischemic Heart Disease study, in which cardiovascular risk factors and clinical status were assessed in 1963, 1965, and 1968, when subjects were 40–70 years of age. Groups of men were stratified according to quartiles of SD of weight change among 3 measurements (1963/1965/1968): ≤1.15 kg, 1.16–1.73 kg, 1.74–2.65 kg, and ≥2.66 kg. The prevalence of dementia was assessed more than 36 years later in approximately one-sixth of them who survived until 1999/2000 (minimum age 76 years) and underwent cognitive evaluation (n = 1,620). Results: Survivors9 dementia prevalence rates were 13.4%, 18.4%, 20.1%, and 19.2% in the first to fourth quartiles of weight change SD, respectively (p for trend = 0.034). Compared to the first quartile of weight change SD and adjusted for diabetes mellitus, body height, and socioeconomic status, a multivariate analysis demonstrated that the odds ratio for dementia was 1.42 (95% confidence interval [CI] 0.95–2.13), 1.59 (95% CI 1.05–2.37), and 1.74 (95% CI 1.14–2.64) in quartiles 2–4 of weight change SD respectively. This relationship was independent of the direction of weight changes. Conclusion: Midlife variations in weight may antecede late-life dementia.

30 January 2010 in Dementia and Geriatric Cognitive Disorders
Verified
Journal Article
Closed access
PDF file
RRRamit Ravona-Springer
Ramit Ravona-Springer
XLXiaodong Luo
Xiaodong Luo
JSJames Schmeidler
James Schmeidler
MWMichael Wysocki
Michael Wysocki
GLGerson Lesser
Gerson Lesser
MBMichal Schnaider Beeri
Michal Schnaider Beeri
Background: This study examines whether the association of diabetes with the rate of cognitive decline varies according to dementia severity. Methods: Longitudinal study on subjects residing in nursing homes and assisted living (n = 342). The Mini Mental State Examination (MMSE) was used to measure the rate of cognitive decline in diabetic and nondiabetic subjects who were nondemented (Clinical Dementia Rating, CDR = 0; n = 125), questionably demented (CDR = 0.5; n = 58) or frankly demented (CDR ≧1; n = 89) at baseline. Diagnosis of diabetes was ascertained by review of medical records and history. Results: Diabetes was associated with an increased rate of decline in the MMSE score of questionably demented subjects (p < 0.0001). In frankly demented subjects, diabetes tended to be associated with less cognitive decline (p = 0.04). Diabetes was not associated with the rate of MMSE decline in nondemented subjects (p = 0.89). Conclusion: In individuals with questionable dementia (CDR = 0.5), diabetes is associated with a faster rate of cognitive decline as measured by the MMSE, but not in nondemented (CDR = 0) or frankly demented (CDR ≧1) individuals.

2 June 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
RRRamit Ravona-Springer
Ramit Ravona-Springer
AHAnthony Heymann
Anthony Heymann
JSJames Schmeidler
James Schmeidler
EMErin Moshier
Erin Moshier
JGJames Godbold
James Godbold
MBMichal Schnaider Beeri
Michal Schnaider Beeri
To study the relationships of long-term trajectories of glycemic control with cognitive performance in cognitively normal elderly with type 2 diabetes (T2D). Subjects (n = 835) pertain to a diabetes registry (DR) established in 1998 with an average of 18 HbA1c measurements per subject, permitting identification of distinctive trajectory groups of HbA1c and examining their association with cognitive function in five domains: episodic memory, semantic categorization, attention/working memory, executive function, and overall cognition. Analyses of covariance compared cognitive function among the trajectory groups adjusting for sociodemographic, cardiovascular, diabetes-related covariates and depression. Subjects averaged 72.8 years of age. Six trajectories of HbA1c were identified, characterized by HbA1c level at entry into the DR (Higher/Lower), and trend over time (Stable/Decreasing/Increasing). Both groups with a trajectory of decreasing HbA1c levels had high HbA1c levels at entry into the DR (9.2%, 10.7%), and high, though decreasing, HbA1c levels over time. They had the worst cognitive performance, particularly in overall cognition (p<0.02) and semantic categorization (p<0.01), followed by that of subjects whose HbA1c at entry into the DR was relatively high (7.2%, 7.8%) and increased over time. Subjects with stable HbA1c over time had the lowest HbA1c levels at entry (6.0%, 6.8%) and performed best in cognitive tests. Glycemic control trajectories, which better reflect chronicity of T2D than a single HbA1c measurement, predict cognitive performance. A trajectory of stable HbA1c levels over time is associated with better cognitive function.

1 November 2011 in Expert Review of Neurotherapeutics
Verified
Journal Article
Closed access
RRRamit Ravona-Springer
Ramit Ravona-Springer
MSMichal Schnaider-Beeri
Michal Schnaider-Beeri
Diabetes and prediabetic states have consistently been shown to be risk factors for cognitive decline, mild cognitive impairment and dementia. The importance of these findings is that diabetes and ...

8 April 2016 in Diabetes Care
Verified
Journal Article
Open access
PDF file
ALAbigail Livny
Abigail Livny
RRRamit Ravona-Springer
Ramit Ravona-Springer
AHAnthony Heymann
Anthony Heymann
RPRachel Priess
Rachel Priess
TKTammar Kushnir
Tammar Kushnir
MBMichal Schnaider Beeri
Michal Schnaider Beeri
OBJECTIVE: We assessed whether the apolipoprotein ε4 (APOE4) genotype affects the relationship of variability in long-term glycemic control (measured by HbA1c SD of multiple measurements) with white matter hyperintensities (WMHs) in elderly patients with type 2 diabetes (T2D). RESEARCH DESIGN AND METHODS: WMH volume was generated from structural T1 and fluid-attenuated inversion recovery MRI in each subject. The analysis included 124 subjects; 27 (21.8%) had one or more APOE4 alleles. RESULTS: HbA1c variability was associated with significantly higher WMH in APOE4 carriers (r = 0.47, P = 0.03), controlling for age, sex, mean HbA1c, number of follow-up years, and a composite of cardiovascular risk factors, but not in noncarriers (r = −0.04, P = 0.71; P for interaction = 0.050). CONCLUSIONS: The results suggest that the APOE4 genotype affects the relationship of long-term glycemic control with WMH load so that APOE4 carriers may be more vulnerable to the insults of poor control.